The purpose of this study is to assess the incidence of rheumatologic flares, changes in pain scores (VAS), changes in functional outcomes (PROMIS), wound complications, surgical site infections, and return trips to the operating room for rheumatology patients following shoulder replacements, comparing those who stop their immunosuppressants preoperatively for the same amount of time as suggested in the literature for hip and knee arthroplasty versus those who hold the medications for a shorter period of time preoperatively.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of wound complications
Timeframe: 90-day post operation
Incidence of superficial surgical site infections
Timeframe: 90-day post operation
Incidence of deep surgical site infections
Timeframe: 90-day post operation
Incidence of return trips to the operating room
Timeframe: 90-day post operation
Incidence of rheumatologic disease flares
Timeframe: 90-day post operation